Galectin Therapeutics Inc.
US ˙ NasdaqCM ˙ US3632252025

SecurityGALT / Galectin Therapeutics Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Wolverine Trading, Llc ownership in GALT / Galectin Therapeutics Inc.

On November 14, 2022 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Galectin Therapeutics Inc. (US:GALT) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 15, 2022 disclosing 12,310 shares of Galectin Therapeutics Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (GALT) in the form of stock options. The firm currently holds call options representing 18,000 of underlying shares valued at $75,960 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GALT / Galectin Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -12,310 -100.00 0 -100.00
2022-08-15 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 12,310 -4,049 -24.75 15 -46.43 0.0000
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 16,359 16,359 28 0.0000
2021-08-06 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -16,572 -100.00 0 -100.00
2021-05-14 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 16,572 16,572 34 0.0001
2020-11-13 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -13,376 -100.00 0 -100.00
2020-08-13 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 13,376 13,376 41 0.0001
2020-02-12 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -11,471 -100.00 0 -100.00
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 11,471 11,471 42 0.0001
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -21,139 -100.00 0 -100.00
2019-02-13 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 21,139 4,012 23.43 80 -22.33 0.0002
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 17,127 17,127 103 0.0002
2018-02-14 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -17,407 -100.00 0 -100.00
2017-11-15 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 17,407 -7,559 -30.28 37 -37.29 0.0001
2017-08-14 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 24,966 -4,090 -14.08 59 68.57 0.0003
2016-11-14 2016-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 29,056 28,976 36,220.00 35 -72.22 0.0002
2016-08-15 2016-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 80 80 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 18,000 62.16 76 200.00 n/a n/a n/a
2025-08-18 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 11,100 -18.98 26 25.00 n/a n/a n/a
2025-05-15 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 13,700 -69.62 21 -59.18 n/a n/a n/a
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 45,100 50 n/a n/a n/a
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 10,900 26 n/a n/a n/a
2023-02-14 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 16,900 48.25 28 100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 11,400 14.00 14 -17.65 n/a n/a n/a
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 10,000 17 n/a n/a n/a
2021-11-12 2021-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-06 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 20,500 91.59 71 222.73 n/a n/a n/a
2021-05-14 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 10,700 -34.36 22 -40.54 n/a n/a n/a
2021-02-12 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 16,300 25.38 37 -13.95 n/a n/a n/a
2020-11-13 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 13,000 43 n/a n/a n/a
2020-08-13 2020-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-11 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 22,200 44 n/a n/a n/a
2020-02-12 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 10,000 -28.06 36 -37.93 n/a n/a n/a
2019-08-20 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 13,900 -31.53 58 -44.23 n/a n/a n/a
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 20,300 50.37 104 103.92 n/a n/a n/a
2019-02-13 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 13,500 -60.76 51 -75.36 n/a n/a n/a
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 34,400 -4.97 207 20.35 n/a n/a n/a
2018-08-13 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 36,200 0.00 172 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 36,200 172 n/a n/a n/a
2018-02-14 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 62,800 -8.19 134 -17.28 n/a n/a n/a
2017-08-14 2017-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 68,400 362.16 162 800.00 n/a n/a n/a
2016-11-14 2016-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 14,800 18 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-18 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 16,700 -53.35 25 -35.90 n/a n/a n/a
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 35,800 39 n/a n/a n/a
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 18,300 -9.85 23 -34.29 n/a n/a n/a
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 20,300 66.39 35 34.62 n/a n/a n/a
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 12,200 26 n/a n/a n/a
2021-08-06 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 24,800 50 n/a n/a n/a
2020-05-11 2020-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-12 2019-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 16,400 -1.80 46 -24.59 n/a n/a n/a
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 16,700 -13.92 61 -24.69 n/a n/a n/a
2019-08-20 2019-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 19,400 -45.20 81 -55.25 n/a n/a n/a
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 35,400 -12.81 181 18.30 n/a n/a n/a
2019-02-13 2018-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 40,600 35.79 153 -15.00 n/a n/a n/a
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 29,900 34.08 180 69.81 n/a n/a n/a
2018-08-13 2018-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 22,300 0.00 106 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 22,300 106 n/a n/a n/a
2018-02-14 2017-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 14,200 -55.49 30 -23.08 n/a n/a n/a
2016-11-14 2016-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 31,900 39 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.